Do nonglycaemic effects such as weight loss account for HbA1c lowering with efpeglenatide?: Insights from the AMPLITUDE-O trial. Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Gerstein, Hertzel Chaim
  • Yang, Mu
  • Lee, Shun Fu
  • Branch, Kelley RH
  • Del Prato, Stefano
  • Lam, Carolyn SP
  • Lopes, Renato D
  • Pratley, Richard
  • Rosenstock, Julio
  • Sattar, Naveed

publication date

  • December 2024